4//SEC Filing
Rochlin Kate 4
Accession 0001209191-23-058716
CIK 0001740279other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:22 AM ET
Size
9.5 KB
Accession
0001209191-23-058716
Insider Transaction Report
Form 4
IN8BIO, INC.INAB
Rochlin Kate
Chief Operating Officer
Transactions
- Award
Common Stock
2023-12-13+12,295→ 17,558 total - Award
Series A Warrants (right to buy)
2023-12-13+12,295→ 12,295 totalExercise: $1.25Exp: 2025-06-13→ Common Stock (12,295 underlying) - Award
Series B Warrants (right to buy)
2023-12-13+12,295→ 12,295 totalExercise: $1.50Exp: 2028-12-13→ Common Stock (12,295 underlying)
Footnotes (2)
- [F1]The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.
- [F2]Fully vested and exercisable.
Documents
Issuer
IN8BIO, INC.
CIK 0001740279
Entity typeother
Related Parties
1- filerCIK 0001898521
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 8:22 AM ET
- Size
- 9.5 KB